Berman Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Berman Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.29M	Buy	2,266 +477	+27%	+$262K	0.2%	61
2021 Q2	$901K	Buy	1,789 +264	+17%	+$125K	0.14%	72
2021 Q1	$695K	Buy	1,525 +211	+16%	+$101K	0.15%	71
2020 Q4	$611K	Buy	1,314 +83	+7%	+$38.9K	0.15%	75
2020 Q3	$543K	Sell	1,231 -3	-0.2%	-$1.24K	0.15%	70
2020 Q2	$446K	Buy	1,234 +201	+19%	+$67.4K	0.12%	74
2020 Q1	$292K	Buy	1,033 +248	+32%	+$78.2K	0.09%	87
2019 Q4	$254K	Buy	785 +20	+3%	+$6.06K	0.07%	117
2019 Q3	$222K	Buy	765 +28	+4%	+$8.02K	0.07%	118
2019 Q2	$216K	Buy	737 +67	+10%	+$18.5K	0.07%	125
2019 Q1	$183K	Buy	670 +130	+24%	+$32.4K	0.06%	132
2018 Q4	$120K	Buy	+540	New	+$127K	0.05%	154

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Berman Capital Advisors's TMO Position: Q3 2021 in Review

Berman Capital Advisors increased its Thermo Fisher Scientific (TMO) stake by 27% in Q3 2021, buying an estimated $262K and bringing the position to 2,266 shares worth $1.29M. The position accounts for 0.2% of the portfolio, ranked #61.

Berman Capital Advisors first reported a position in TMO in Q4 2018 and has held it in 12 quarters since. 2,129 funds tracked by Wall St. Rank hold TMO as of Q3 2021.

Berman Capital Advisors held 2,266 shares of Thermo Fisher Scientific worth $1.29M as of Q3 2021.
Berman Capital Advisors bought 477 Thermo Fisher Scientific shares in Q3 2021, an estimated $262K.
Thermo Fisher Scientific made up 0.2% of Berman Capital Advisors's portfolio in Q3 2021, its #61 holding.
Berman Capital Advisors first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 12 quarters since.
2,129 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.